Literature DB >> 26663351

Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice.

Giulio Marchesini1, Salvatore Petta2, Riccardo Dalle Grave3.   

Abstract

Fatty liver accumulation results from an imbalance between lipid deposition and removal, driven by the hepatic synthesis of triglycerides and de novo lipogenesis. The habitual diet plays a relevant role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD), and both risky (e.g., fructose) and protective foods (Mediterranean diet) have been described, but the contribution of excess calories remains pivotal. Accordingly, weight loss is the most effective way to promote liver fat removal. Several controlled studies have confirmed that an intense approach to lifestyle changes, carried on along the lines of cognitive-behavior treatment, is able to attain the desired 7%-10% weight loss, associated with reduced liver fat, nonalcoholic steatohepatitis (NASH) remission, and also reduction of fibrosis. Even larger effects are reported after bariatric surgery-induced weight loss in NAFLD, where 80% of subjects achieve NASH resolution at 1-year follow-up. These results provide solid data to evaluate the safety and effectiveness of the pharmacological treatment of NASH. The battle against metabolic diseases, largely fueled by increased liver fat, needs a comprehensive approach to be successful in an obesiogenic environment. In this review, we will discuss the role of hepatic lipid metabolism, genetic background, diet, and physical activity on fatty liver. They are the basis for a lifestyle approach to NAFLD treatment. (Hepatology 2016;63:2032-2043).
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2016        PMID: 26663351     DOI: 10.1002/hep.28392

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  81 in total

1.  Copper modulates sex-specific fructose hepatoxicity in nonalcoholic fatty liver disease (NALFD) Wistar rat models.

Authors:  Austin Morrell; Brian P Tripet; Brian J Eilers; Megan Tegman; Damon Thompson; Valérie Copié; Jason L Burkhead
Journal:  J Nutr Biochem       Date:  2019-12-16       Impact factor: 6.048

Review 2.  Lifestyle Intervention as the Primary Treatment for Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Taisa Kohut; Jennifer Panganiban
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

Review 3.  Effects of dietary macronutrients on liver fat content in adults: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Esther Winters-van Eekelen; Inge Verkouter; Harry P F Peters; Marjan Alssema; Babette G de Roos; Vera B Schrauwen-Hinderling; Kay H M Roumans; Jan W Schoones; Peter L Zock; Patrick Schrauwen; Frits R Rosendaal; Olaf M Dekkers; Renée de Mutsert
Journal:  Eur J Clin Nutr       Date:  2020-10-22       Impact factor: 4.016

Review 4.  Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults.

Authors:  Elena S George; Adrienne Forsyth; Catherine Itsiopoulos; Amanda J Nicoll; Marno Ryan; Siddharth Sood; Stuart K Roberts; Audrey C Tierney
Journal:  Adv Nutr       Date:  2018-01-01       Impact factor: 8.701

5.  Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.

Authors:  Chofit Chai; Bryan Cox; Dayana Yaish; Devora Gross; Nofar Rosenberg; Franck Amblard; Zohar Shemuelian; Maytal Gefen; Amit Korach; Oren Tirosh; Tali Lanton; Henrike Link; Joseph Tam; Anna Permyakova; Gunes Ozhan; Jonathan Citrin; Haixing Liao; Mirna Tannous; Michal Hahn; Jonathan Axelrod; Enara Arretxe; Cristina Alonso; Ibon Martinez-Arranz; Pablo Ortiz Betés; Rifaat Safadi; Ahmad Salhab; Johnny Amer; Zahira Tber; Seema Mengshetti; Hilla Giladi; Raymond F Schinazi; Eithan Galun
Journal:  Gastroenterology       Date:  2020-05-22       Impact factor: 22.682

Review 6.  Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease.

Authors:  Christine C Hsu; Erik Ness; Kris V Kowdley
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

7.  Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.

Authors:  Francesco Baratta; Daniele Pastori; Licia Polimeni; Tommaso Bucci; Fabrizio Ceci; Cinzia Calabrese; Ilaria Ernesti; Gaetano Pannitteri; Francesco Violi; Francesco Angelico; Maria Del Ben
Journal:  Am J Gastroenterol       Date:  2017-10-24       Impact factor: 10.864

8.  Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.

Authors:  Marcin Krawczyk; Monika Rau; Jörn M Schattenberg; Heike Bantel; Anita Pathil; Münevver Demir; Johannes Kluwe; Tobias Boettler; Frank Lammert; Andreas Geier
Journal:  J Lipid Res       Date:  2016-11-11       Impact factor: 5.922

9.  Centrilobular ductular reaction correlates with fibrosis stage and fibrosis progression in non-alcoholic steatohepatitis.

Authors:  Lei Zhao; Maria Westerhoff; Rish K Pai; Won-Tak Choi; Zu-Hua Gao; John Hart
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842

Review 10.  Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.

Authors:  M Noureddin; Q M Anstee; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2016-04-08       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.